Notably, a subpopulation of CTHRC1-positive pathological fibroblasts was increased in lungs affected by COVID-19 [20,101] and was associated with the progression of pulmonary fibrosis in COVID-19 patients [61,110,113]. This evidence concerns the gene CTHRC1 and pulmonary fibrosis.